Growth factors and cancer.
暂无分享,去创建一个
[1] A. Ogura,et al. Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line , 1985, Nature.
[2] T. Pawson,et al. Interactions of phosphatidylinositol kinase, GTPase-activating protein (GAP), and GAP-associated proteins with the colony-stimulating factor 1 receptor , 1990, Molecular and cellular biology.
[3] T. Jessell,et al. Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. , 1989, Science.
[4] P. Comoglio,et al. c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase. , 1991, Oncogene.
[5] J. Schlessinger,et al. Signal transduction through the EGF receptor transfected in IL-3-dependent hematopoietic cells. , 1988, Science.
[6] T. Pollard,et al. Regulation of phospholipase C-gamma 1 by profilin and tyrosine phosphorylation. , 1991, Science.
[7] Joseph Schlessinger,et al. Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.
[8] Christopher T Denny,et al. Leukemia and the disruption of normal hematopoiesis , 1991, Cell.
[9] Charles J. Sherr,et al. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF 1 , 1985, Cell.
[10] Stephen H. Friend,et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma , 1986, Nature.
[11] Hermona Soreq,et al. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin , 1985, Nature.
[12] C. Molloy,et al. The erbB-2 mitogenic signaling pathway: tyrosine phosphorylation of phospholipase C-gamma and GTPase-activating protein does not correlate with erbB-2 mitogenic potency , 1991, Molecular and cellular biology.
[13] G. Inghirami,et al. Transformation and plasmacytoid differentiation of EBV-infected human B lymphoblasts by ras oncogenes. , 1989, Science.
[14] S. Heinemann,et al. Cholinergic metabolism and synapse formation by a rat nerve cell line. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[15] J B Gibbs,et al. Modulation of guanine nucleotides bound to Ras in NIH3T3 cells by oncogenes, growth factors, and the GTPase activating protein (GAP). , 1990, The Journal of biological chemistry.
[16] R. Levi‐montalcini,et al. The nerve growth factor 35 years later. , 1987, Science.
[17] K. Semba,et al. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. Parsons,et al. Transformation by pp60src or stimulation of cells with epidermal growth factor induces the stable association of tyrosine-phosphorylated cellular proteins with GTPase-activating protein , 1991, Molecular and cellular biology.
[19] T. Hirano,et al. Molecular cloning and expression of an IL-6 signal transducer, gp130 , 1990, Cell.
[20] M. Hayman,et al. Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[21] S. Aaronson,et al. Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. , 1989, Science.
[22] P. Casey,et al. Inhibition of purified p21 ras farnesyl:protein transferase by Cys-AAX tetrapeptides , 1990, Cell.
[23] M. Ittmann,et al. An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family , 1987, Cell.
[24] T. Matsui,et al. FGF modulates the PDGF-driven pathway of oligodendrocyte development , 1990, Neuron.
[25] M. Brann,et al. Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[26] S. Courtneidge,et al. An 81 kd protein complexed with middle T antigen and pp60c-src : A possible phosphatidylinositol kinase , 1987, Cell.
[27] T. Hunter,et al. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine , 1980, Proceedings of the National Academy of Sciences.
[28] J. Bishop,et al. The product of the protooncogene c-src is modified during the cellular response to platelet-derived growth factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[29] R. Erikson,et al. Protein kinase activity associated with the avian sarcoma virus src gene product. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[30] S. Larson,et al. Clinical Use of a Monoclonal Antibody to Bombesin‐like Peptide in Patients with Lung Cancer a, b , 1988, Annals of the New York Academy of Sciences.
[31] R. Kumar,et al. Regulation of phosphorylation of the c-erbB-2/HER2 gene product by a monoclonal antibody and serum growth factor(s) in human mammary carcinoma cells , 1991, Molecular and cellular biology.
[32] A. Wolfman,et al. A cytosolic protein catalyzes the release of GDP from p21ras. , 1990, Science.
[33] E. Gherardi,et al. Hepatocytes and scatter factor , 1990, Nature.
[34] D. Burstein,et al. Activated N‐ras gene induces neuronal differentiation of PC12 rat pheochromocytoma cells , 1986, Journal of cellular physiology.
[35] M. Ruggiero,et al. Macrophage-colony-stimulating factor (CSF-1) induces proliferation, chemotaxis, and reversible monocytic differentiation in myeloid progenitor cells transfected with the human c-fms/CSF-1 receptor cDNA. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[36] J. Bishop. Molecular themes in oncogenesis , 1991, Cell.
[37] D. Golde,et al. Treatment of hairy-cell leukemia. , 1990, Blood reviews.
[38] L. Lazarus,et al. Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly. Effects of dose and frequency and long-term safety. , 1990, Annals of internal medicine.
[39] D. Smith,et al. The v-sea oncogene of avian erythroblastosis retrovirus S13: another member of the protein-tyrosine kinase gene family. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[40] W. McGuire,et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.
[41] A. Schally. Oncological applications of somatostatin analogues. , 1988, Cancer research.
[42] P. H. Seeburg,et al. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes , 1985, Nature.
[43] A. Levine,et al. The p53 tumour suppressor gene , 1991, Nature.
[44] R. Weinberg,et al. Malignant transformation of mouse primary keratinocytes by Harvey sarcoma virus and its modulation by surrounding normal cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[45] M. Pike,et al. Increased cell division as a cause of human cancer. , 1990, Cancer research.
[46] T. Fleming,et al. PDGF induction of tyrosine phosphorylation of GTPase activating protein , 1989, Nature.
[47] J. L. Bos,et al. ras oncogenes in human cancer: a review. , 1989, Cancer research.
[48] A. Ullrich,et al. Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases , 1991, Cell.
[49] M. Kraus,et al. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[50] D. Spandidos,et al. Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression. , 1987, British Journal of Cancer.
[51] A. Ullrich,et al. Ligand activation of overexpressed epidermal growth factor receptors transforms NIH 3T3 mouse fibroblasts. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[52] G. Carpenter,et al. EPIDERMAL GROWTH FACTOR * , 1982, The Journal of biological chemistry.
[53] D. Lowy,et al. Suppression of c-ras transformation by GTPase-activating protein , 1990, Nature.
[54] M J Bissell,et al. The embryonic environment strongly attenuates v-src oncogenesis in mesenchymal and epithelial tissues, but not in endothelia , 1990, The Journal of cell biology.
[55] H. Moses,et al. Regulation of epithelial proliferation by TGF-beta. , 1991, Ciba Foundation symposium.
[56] A. Ullrich,et al. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells , 1987, Cell.
[57] P. Barr,et al. Acidic and basic fibroblast growth factors stimulate tyrosine kinase activity in vivo. , 1988, The Journal of biological chemistry.
[58] Cori Bargmann,et al. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185 , 1986, Cell.
[59] Nic Jones,et al. Transcriptional regulation by dimerization: Two sides to an incestuous relationship , 1990, Cell.
[60] L. Liotta,et al. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.
[61] M. Barbacid,et al. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences , 1986, Nature.
[62] S. Cannistra,et al. Signal transduction of the human granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors involves tyrosine phosphorylation of a common set of cytoplasmic proteins. , 1990, Blood.
[63] T. Waldmann,et al. Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[64] G. Cunha,et al. Stromal regulation of epithelial function. , 1991, Cancer treatment and research.
[65] E. Pasquale. A distinctive family of embryonic protein-tyrosine kinase receptors. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[66] J. Ihle,et al. Stimulation of factor-dependent myeloid cell lines with interleukin 3 induces tyrosine phosphorylation of several cellular substrates. , 1988, The Journal of biological chemistry.
[67] Teruhiko Yoshida,et al. K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[68] T. Fleming,et al. Autocrine interaction between TGF alpha and the EGF-receptor: quantitative requirements for induction of the malignant phenotype. , 1989, Oncogene.
[69] H. Kung,et al. Purification of a factor capable of stimulating the guanine nucleotide exchange reaction of ras proteins and its effect on ras-related small molecular mass G proteins. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[70] T. Fleming,et al. Autocrine mechanism for v-sis transformation requires cell surface localization of internally activated growth factor receptors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[71] G. Carpenter,et al. Epidermal Growth Factor , 2002 .
[72] Frank McCormick,et al. ras GTPase activating protein: Signal transmitter and signal terminator , 1989, Cell.
[73] Tony Hunter,et al. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity , 1991, Cell.
[74] W. Pledger,et al. Epidermal growth factor (EGF) is required only during the traverse of early G1 in PDGF stimulated density-arrested BALB/c-3T3 cells. , 1983, Experimental cell research.
[75] A. Balmain,et al. Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene , 1983, Nature.
[76] S. Lamberts,et al. Potential role of somatostatin analogues in the treatment of cancer , 1987, European journal of clinical investigation.
[77] L. Cantley,et al. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation , 1985, Nature.
[78] W Godolphin,et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.
[79] A. Ullrich,et al. Growth factor receptor tyrosine kinases. , 1988, Annual review of biochemistry.
[80] T. Hunter,et al. Phospholipase C-γ is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro , 1989, Cell.
[81] G. Panayotou,et al. Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase , 1991, Cell.
[82] A. Levitzki,et al. Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors , 1988, Science.
[83] G. Michalopoulos,et al. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. , 1989, Cancer research.
[84] A. Balmain,et al. Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter , 1990, Cell.
[85] J. Rubin,et al. Characterization of the receptor for keratinocyte growth factor. Evidence for multiple fibroblast growth factor receptors. , 1990, The Journal of biological chemistry.
[86] A. Ullrich,et al. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences , 1984, Nature.
[87] G. Carpenter,et al. Increase of the catalytic activity of phospholipase C-gamma 1 by tyrosine phosphorylation. , 1990, Science.
[88] M. Montminy,et al. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133 , 1989, Cell.
[89] R. Gallo,et al. Human T-lymphotropic retroviruses , 1985, Nature.
[90] P. Nowell,et al. BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[91] M. Okigaki,et al. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. , 1989, Biochemical and biophysical research communications.
[92] N. Nomura,et al. High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. , 1986, Cancer research.
[93] C R King,et al. Amplification of a novel v-erbB-related gene in a human mammary carcinoma. , 1985, Science.
[94] W. Lee,et al. Human retinoblastoma susceptibility gene: cloning, identification, and sequence , 1987, Science.
[95] L. Greene,et al. Nerve growth factor-induced increase in electrical excitability and acetylcholine sensitivity of a rat pheochromocytoma cell line , 1977, Nature.
[96] R. Schreiber,et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death , 1990, Nature.
[97] S. Alemà,et al. Differentiation of PC12 phaeochromocytoma cells induced by v-src oncogene , 1985, Nature.
[98] S. Hirono,et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. , 1988, The Journal of clinical investigation.
[99] David L. Vaux,et al. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.
[100] H. Kung,et al. Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein , 1984, Nature.
[101] B. Ames,et al. Too many rodent carcinogens: mitogenesis increases mutagenesis. , 1990, Science.
[102] W. Richardson,et al. Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture , 1988, Nature.
[103] D. Metcalf,et al. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells , 1989, Nature.
[104] Michael J. Berridge,et al. Inositol phosphates and cell signalling , 1989, Nature.
[105] R. Tjian,et al. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. , 1989, Science.
[106] Harold L. Moses,et al. TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights , 1990, Cell.
[107] A. Ullrich,et al. p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor , 1989, Molecular and cellular biology.
[108] A. Ashkenazi,et al. The structural and functional interrelationships of muscarinic acetylcholine receptor subtypes , 1989, BioEssays : news and reviews in molecular, cellular and developmental biology.
[109] D. Morrison,et al. Direct activation of the serine/threonine kinase activity of raf-1 through tyrosine phosphorylation by the PDGF β-receptor , 1989, Cell.
[110] T. Pawson,et al. raf family serine/threonine protein kinases in mitogen signal transduction. , 1988, Cold Spring Harbor symposia on quantitative biology.
[111] John D. Minna,et al. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer , 1985, Nature.
[112] S. Sell. Cancer markers of the 1990s. Comparison of the new generation of markers defined by monoclonal antibodies and oncogene probes to prototypic markers. , 1990, Clinics in laboratory medicine.
[113] Robert H. Collins,et al. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. , 1987, The New England journal of medicine.
[114] J. Auwerx,et al. IP-1: A dominant inhibitor of Fos/Jun whose activity is modulated by phosphorylation , 1991, Cell.
[115] C. March,et al. A new cytokine receptor superfamily. , 1990, Trends in biochemical sciences.
[116] M. White,et al. Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity , 1987, Cell.
[117] M. Shibuya,et al. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. , 1990, Oncogene.
[118] V. Fried,et al. Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. , 1989, Science.
[119] L. Cantley,et al. Oncogenes and signal transduction , 1991, Cell.
[120] J. Rubin,et al. A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[121] M. Santoro,et al. A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases , 1987, Nature.
[122] M. Wigler,et al. Genetic analysis of mammalian GAP expressed in yeast , 1989, Cell.
[123] J. Partanen,et al. FGFR‐4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. , 1991, The EMBO journal.
[124] C. Stiles,et al. An ordered sequence of events is required before BALB/c-3T3 cells become committed to DNA synthesis. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[125] J. Trimmer,et al. Monoclonal antibody to a membrane glycoprotein inhibits the acrosome reaction and associated Ca2+ and H+ fluxes of sea urchin sperm , 1985, Cell.
[126] M. Barbacid,et al. The trk proto-oncogene encodes a receptor for nerve growth factor , 1991, Cell.
[127] D. Kaplan,et al. Induction by NGF of meiotic maturation of Xenopus oocytes expressing the trk proto-oncogene product. , 1991, Science.
[128] J. Rubin,et al. Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop. , 1991, Science.
[129] David M. Livingston,et al. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element , 1989, Cell.
[130] D. Kaplan,et al. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor , 1991, Nature.
[131] Robert A. Weinberg,et al. Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies , 1985, Cell.
[132] R. Halaban,et al. Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes , 1988, The Journal of cell biology.
[133] M. Santoro,et al. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas , 1990, Cell.
[134] Gwyn T. Williams. Programmed cell death: Apoptosis and oncogenesis , 1991, Cell.
[135] G. Guroff,et al. Nerve growth factor-induced alteration in the response of PC12 pheochromocytoma cells to epidermal growth factor , 1981, The Journal of cell biology.
[136] P. Black,et al. Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. , 1990, The Journal of clinical investigation.
[137] T. Pawson,et al. Characterization of elk, a brain-specific receptor tyrosine kinase , 1991, Molecular and cellular biology.
[138] J. Massagué,et al. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation , 1990, Cell.
[139] M. Endo,et al. Platelet-derived growth factor stimulates formation of active p21ras.GTP complex in Swiss mouse 3T3 cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[140] G. Wasserburg,et al. Precise Timing of the Last Interglacial Period from Mass Spectrometric Determination of Thorium-230 in Corals , 1987, Science.
[141] M. Kris,et al. Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer , 1991 .
[142] R. Weinberg,et al. The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen , 1984, Nature.
[143] H. Hirai,et al. A novel putative tyrosine kinase receptor encoded by the eph gene. , 1987, Science.
[144] J. Rubin,et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. , 1991, Science.
[145] A. Brown,et al. ras p21 and GAP inhibit coupling of muscarinic receptors to atrial K+ channels , 1990, Cell.
[146] W. Maltese,et al. Isoprenylated proteins in cultured cells: Subcellular distribution and changes related to altered morphology and growth arrest induced by mevalonate deprivation , 1987, Journal of cellular physiology.
[147] J. Avruch,et al. Endothelin, vasopressin, and angiotensin II enhance tyrosine phosphorylation by protein kinase C-dependent and -independent pathways in glomerular mesangial cells. , 1991, The Journal of biological chemistry.
[148] T. Libermann,et al. Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines. , 1988, Cancer research.
[149] L. M. Leeb-Lundberg,et al. Bradykinin and bombesin rapidly stimulate tyrosine phosphorylation of a 120-kDa group of proteins in Swiss 3T3 cells. , 1991, The Journal of biological chemistry.
[150] C. Heldin,et al. Platelet-derived growth factors: A family of isoforms that bind to two disticnt receptors , 1989 .
[151] P. Nowell,et al. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. , 1984, Science.
[152] C R King,et al. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. , 1987, Science.
[153] H. Lodish,et al. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor , 1990, Nature.
[154] H. Varmus,et al. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. , 1984, Science.
[155] I. Pastan,et al. Recombinant toxins for cancer treatment. , 1991, Science.
[156] J. Yokota,et al. AMPLIFICATION OF c-erbB-2 ONCOGENE IN HUMAN ADENOCARCINOMAS IN VIVO , 1986, The Lancet.
[157] R. Perlmutter,et al. Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association , 1991, Science.
[158] K. Miyagawa,et al. cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[159] S. Singer,et al. Identification of a developmentally regulated protein-tyrosine kinase by using anti-phosphotyrosine antibodies to screen a cDNA expression library. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[160] B. Lewin. Oncogenic conversion by regulatory changes in transcription factors , 1991, Cell.
[161] M. Roussel,et al. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor) , 1987, Nature.
[162] H. Lodish,et al. Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity , 1990, Nature.
[163] B. Weissman,et al. Interactions of growth factors and retroviral oncogenes with mitogenic signal transduction pathways of Balb/MK keratinocytes. , 1988, Oncogene.
[164] J. Broach,et al. The CDC25 protein of Saccharomyces cerevisiae promotes exchange of guanine nucleotides bound to ras , 1991, Molecular and cellular biology.
[165] Y Nishizuka,et al. The protein kinase C family: heterogeneity and its implications. , 1989, Annual review of biochemistry.
[166] J. Shepherd,et al. REGRESSION OF LIVER METASTASES IN PATIENT WITH GASTRIN-SECRETING TUMOUR TREATED WITH SMS 201-995 , 1986, The Lancet.
[167] D. Morrison,et al. Signal transduction from membrane to cytoplasm: growth factors and membrane-bound oncogene products increase Raf-1 phosphorylation and associated protein kinase activity. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[168] H. Lodish,et al. Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[169] T. Hunter,et al. The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor , 1991, Cell.
[170] Y. Tsujimoto,et al. Involvement of the bcl-2 gene in human follicular lymphoma. , 1985, Science.
[171] T. Fleming,et al. Development of a highly efficient expression cDNA cloning system: application to oncogene isolation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[172] L. Cantley,et al. Phosphatidylinositol metabolism and polyoma-mediated transformation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[173] A. Ullrich,et al. Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors , 1986, Nature.
[174] G. Wogan,et al. The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[175] E. Kawasaki,et al. Two G protein oncogenes in human endocrine tumors. , 1990, Science.
[176] Jonathan A. Cooper,et al. Binding of GAP to activated PDGF receptors. , 1990, Science.
[177] S. Courtneidge,et al. Association between the PDGF receptor and members of the src family of tyrosine kinases , 1990, Cell.
[178] W. Schafer,et al. Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans. , 1989, Science.
[179] A. Burgess,et al. Hierarchical down-modulation of hemopoietic growth factor receptors , 1985, Cell.
[180] R. Weinberg. The retinoblastoma gene and cell growth control. , 1990, Trends in biochemical sciences.
[181] R. Weinberg,et al. Identification of a nucleotide exchange-promoting activity for p21ras. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[182] C. Stiles,et al. Induction of DNA synthesis in BALB/c 3T3 cells by serum components: reevaluation of the commitment process. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[183] P. Worley,et al. Muscarinic agonists and phorbol esters increase tyrosine phosphorylation of a 40-kilodalton protein in hippocampal slices. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[184] K. Semba. A v-erbB-related protooncogene, c-erb-B-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma , 1985 .
[185] J. Rowley,et al. The human met oncogene is related to the tyrosine kinase oncogenes , 1985, Nature.
[186] I. Pastan,et al. Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene. , 1987, Science.
[187] J Vandekerckhove,et al. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells , 1990, The Journal of cell biology.
[188] D. Morrison,et al. PDGF β-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex , 1990, Cell.
[189] H. Bourne,et al. GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours , 1989, Nature.
[190] T Pawson,et al. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. , 1991, Science.
[191] W. Pledger,et al. Epidermal growth factor (EGF) and somatomedin C regulate G1 progression in competent BALB/c-3T3 cells. , 1982, Experimental cell research.
[192] M. Caron,et al. Structure of the adrenergic and related receptors. , 1989, Annual review of neuroscience.
[193] John E. Murphy,et al. A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family , 1986, Nature.
[194] K. Tashiro,et al. Molecular cloning and expression of human hepatocyte growth factor , 1989, Nature.
[195] M. Nakafuku,et al. Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, interleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[196] G. Peters,et al. The structure and function of the int-2 oncogene. , 1989, Progress in growth factor research.
[197] A. Ullrich,et al. Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[198] W. Haser,et al. Raf-1: A kinase currently without a cause but not lacking in effects , 1991, Cell.
[199] J. Gil,et al. Bombesin, vasopressin, and endothelin rapidly stimulate tyrosine phosphorylation in intact Swiss 3T3 cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[200] R F Doolittle,et al. Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. , 1983, Science.
[201] A. Schally,et al. Antitumor Effects of Analogs of Hypothalamic Hormones in Endocrine-Dependent Cancers , 1984, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[202] G. Labourdette,et al. Effects of acidic and basic fibroblast growth factors on proliferation and maturation of cultured rat oligodendrocytes , 1989, International Journal of Developmental Neuroscience.
[203] T. Nakamura,et al. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[204] G. Michalopoulos,et al. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. , 1991, Oncogene.
[205] B. Gliniak,et al. Expression of the M-CSF receptor is controlled posttranscriptionally by the dominant actions of GM-CSF or multi-CSF , 1990, Cell.
[206] Paul Stroobant,et al. Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus , 1983, Nature.
[207] C. Heldin,et al. Similar action of platelet‐derived growth factor and epidermal growth factor in the prereplicative phase of human fibroblasts suggests a common intracellular pathway , 1985, Journal of cellular physiology.
[208] A. Pardee. G1 events and regulation of cell proliferation. , 1989, Science.
[209] V. Fried,et al. cDNA cloning of a Novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF β-receptor , 1991, Cell.
[210] T. Hunter,et al. cDNA cloning and characterization of eck, an epithelial cell receptor protein-tyrosine kinase in the eph/elk family of protein kinases , 1990, Molecular and cellular biology.
[211] J. Rubin,et al. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. , 1989, Science.